Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome

Stock Information for Wize Pharma Inc

Loading

Please wait while we load your information from QuoteMedia.